Literature DB >> 9681856

Genotype-phenotype correlations in von Hippel-Lindau disease.

H P Neumann1, B U Bender.   

Abstract

A total of 146 intragenic germline mutations of the von Hippel-Lindau (VHL) gene are known and this figure is still increasing. To date, information for mutation-specific genetic counselling is insufficient, since either the total number of carriers is very low or clinical information and investigation of symptomatic and asymptomatic is incomplete. This review summarizes all known mutations and includes the centres which performed the mutation analyses and may provide further information regarding specific mutations.

Entities:  

Mesh:

Year:  1998        PMID: 9681856     DOI: 10.1046/j.1365-2796.1998.00336.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  17 in total

Review 1.  Renal cancer: oxygen meets metabolism.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

2.  Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents.

Authors:  M T Sgambati; C Stolle; P L Choyke; M M Walther; B Zbar; W M Linehan; G M Glenn
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.

Authors:  S Gläsker; B U Bender; T W Apel; V van Velthoven; L M Mulligan; J Zentner; H P Neumann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

Review 4.  [Retinal angiomatosis. Ocular manifestation of von Hippel-Lindau disease].

Authors:  B Junker; D Schmidt; H T Agostini
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

5.  The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.

Authors:  S Gläsker; B U Bender; T W Apel; E Natt; V van Velthoven; R Scheremet; J Zentner; H P Neumann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

6.  A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.

Authors:  S Cingoz; R B van der Luijt; E Kurt; M Apaydin; I Akkol; Mihriban Heval Ozgen
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

Review 7.  The VHL tumor suppressor and HIF: insights from genetic studies in mice.

Authors:  P P Kapitsinou; V H Haase
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

Review 8.  Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.

Authors:  Elizabeth Cartwright Pfaffenroth; W Marston Linehan
Journal:  Expert Opin Biol Ther       Date:  2008-06       Impact factor: 4.388

Review 9.  Ocular von Hippel-Lindau disease: clinical update and emerging treatments.

Authors:  Wai T Wong; Emily Y Chew
Journal:  Curr Opin Ophthalmol       Date:  2008-05       Impact factor: 3.761

Review 10.  Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum.

Authors:  Susanne Schlisio
Journal:  J Cell Mol Med       Date:  2009-08-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.